Hasegawa Hirofumi, Inokuchi Shoichi, Kitagawa Dai, Shibahara Kotaro, Funahashi Satoru, Kitamura Masayuki
Dept. of Surgery, Saiseikai Yahata General Hospital.
Gan To Kagaku Ryoho. 2018 Mar;45(3):548-550.
As the treatment for the liposarcoma, there is no effective chemotherapy and a surgical remedy is required. We present the case of a 64-year-old man who complained about difficulty in swallowing and discomfort of throat. Computed tomography revealed a large enhancing left sided retroperitoneal mass invading the retroperitoneal space and it was displaced to the right. Preoperative diagnosis was retroperitonealmal ignant tumor. Tumor excision were performed and around 4.0 kg tumor was removed though its size was too big and resected it separately. Tumors increased 5 months later and became the second enucleation. After the second operation, we used eribulin as postoperative adjuvant chemotherapy. However, we needed extraction 3 times by the surgery because it recurred as peritonealdissemination. We continue surgicaltreatment and chemotherapy together as there are a part increasing relatively slowly and a high grade part increasing rapidly.
作为脂肪肉瘤的治疗方法,目前尚无有效的化疗方案,需要进行手术治疗。我们报告一例64岁男性患者,他主诉吞咽困难和咽喉不适。计算机断层扫描显示左侧腹膜后有一个巨大的强化肿块,侵犯了腹膜后间隙并向右移位。术前诊断为腹膜后恶性肿瘤。进行了肿瘤切除术,尽管肿瘤体积太大,分块切除了约4.0kg的肿瘤。5个月后肿瘤复发,进行了第二次摘除术。第二次手术后,我们使用艾日布林作为术后辅助化疗。然而,由于肿瘤复发为腹膜播散,我们需要进行3次手术切除。由于存在部分增长相对缓慢和部分高级别部分增长迅速的情况,我们继续同时进行手术治疗和化疗。